Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIROFIBAN for Antiplatelet therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,513 adverse event reports in the FDA FAERS database where TIROFIBAN was used for Antiplatelet therapy.

Most Reported Side Effects for TIROFIBAN

Side Effect Reports % Deaths Hosp.
Haemorrhage 341 15.7% 1 2
Angina pectoris 177 8.2% 0 19
Haemorrhage intracranial 170 7.9% 2 1
Myocardial infarction 159 7.3% 5 1
Thrombocytopenia 150 6.9% 10 23
Cardiac failure acute 116 5.4% 0 0
Death 110 5.1% 110 5
Acute respiratory failure 99 4.6% 1 3
Cerebral haemorrhage 84 3.9% 15 7
Cardiac failure 68 3.1% 5 1
Vascular stent thrombosis 63 2.9% 2 10
Infarction 53 2.5% 0 0
Cardiac death 29 1.3% 28 0
Arrhythmia 25 1.2% 0 0
Gastrointestinal haemorrhage 24 1.1% 3 3

Other Indications for TIROFIBAN

Ischaemic stroke (220) Off label use (162) Acute myocardial infarction (75) Product used for unknown indication (58) Acute coronary syndrome (32) Angina unstable (23) Myocardial infarction (13) Thrombosis (11) Cerebral infarction (10) Cardiovascular event prophylaxis (9)

Other Drugs Used for Antiplatelet therapy

CLOPIDOGREL BISULFATE (3,520) ASPIRIN (3,410) TICAGRELOR (660) PRASUGREL (235) HEPARIN (96) EPTIFIBATIDE (60) ASPIRIN DL-LYSINE (59) WARFARIN (59) CILOSTAZOL (53) CANGRELOR (41)

Related Pages

TIROFIBAN Full Profile All Antiplatelet therapy Drugs TIROFIBAN Demographics TIROFIBAN Timeline